This Senator Just Sold Up To $465K In Clorox Stock

The Office of Senator Thomas H Tuberville has reported a sale of Clorox CLX stock on November 16, 2023. According to the November filing, the transaction was made on November 16, 2023.

What Happened: A recent report from the U.S. Senate's Office on November 16, 2023 reveals that Tuberville made a sale of Clorox stock valued between $161,006 - $465,000.

Clorox shares are trading up 0.68% at $140.0 at the time of writing.

Why Congressional Transactions Matter

Congressional transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.

A Congressional transaction is when any Representative or Senator either buys or sells an individual stock. Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.

When a Senator or Representative makes a new purchase, that could be an indication that they expect the stock to rise.

A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down.

In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.

Trade Recap

A November filing states that Alabama Senator Thomas H Tuberville sold shares of Clorox. The exact amount of the transaction remained unknown but the filing states a range of $161,006 - $465,000.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!